Emerging Role of Biosimilars in Oncology-Hematology in Saudi Arabia: A Practical Perspective [0.03%]
从实际角度出发探讨沙特阿拉伯生物仿制药在肿瘤-血液学中所起的作用及其发展趋势
Mansoor A Khan,Mohammed A Aseeri,Majed A Alshamrani et al.
Mansoor A Khan et al.
Biologics are significant drivers of globally escalating healthcare costs. Biosimilars have potential to offer cost savings with comparable efficacy and safety to innovator products and increase the access of treatment to more patients. Thi...
Abrar Al-Subhi,Mansoor Ahmed Khan,Mohammed A Aseeri
Abrar Al-Subhi
Introduction: Medication-use evaluation (MUE) is a performance improvement method used to achieve optimal patient outcomes. The recombinant human factor VIIa (rFVIIa) (NovoSeven) is an expensive agent approved by the U.S....
Francisco Rocha-Gonçalves
Francisco Rocha-Gonçalves
Francisco Nuno Rocha-Gonçalves
Francisco Nuno Rocha-Gonçalves
Pedro Cardoso,C Santos,Francisco Rocha-Gonçalves
Pedro Cardoso
Therapeutic drug monitoring (TDM) has as its main objective to ensure that the plasma drug concentration remains within the appropriate range. Regarding the economic dimension of TDM, it is known that there are gains in health outcomes; how...
Abdul Rahman Jazieh
Abdul Rahman Jazieh
Outcomes Management in a Real-World Evidence Context: The Case of Abiraterone and Enzalutamide in the Treatment of Metastatic Castration-Resistant Prostate Cancer [0.03%]
真实世界证据背景下结局管理的研究及案例——阿比特龙和恩杂鲁胺治疗转移性去势抵抗性前列腺癌的疗效研究
Pedro Cardoso,C Santos,F Costa et al.
Pedro Cardoso et al.
At present, for patients with metastatic and castration-resistant prostate cancer, European Society for Medical Oncology and National Comprehensive Cancer Network guidelines recommend enzalutamide (E) or abiraterone (A). There are still a f...
Cost-Effectiveness Analysis of Supply Chain System: Sudan's National Medical Supplies Fund 2011-2014 [0.03%]
供应链系统的成本效益分析：苏丹国家医疗用品基金(2011-2014)
Ayat Mohammed Elhassan Makkawi,Mohamed Awad Mousnad,Gamal Khalafalla Mohamed
Ayat Mohammed Elhassan Makkawi
Introduction: The objective of this study was to evaluate the economic impact of supply chain investment on the performance of the National Supply System of Essential Medicines in Sudan from 2011 to 2014. ...
Health Economic Publications From the Middle East and North Africa Region: A Scoping Review of the Volume and Methods of Research [0.03%]
中东和北非地区的卫生经济学文献综述：研究数量与方法学
Zsombor Zrubka,Omar Rashdan,László Gulácsi
Zsombor Zrubka
Introduction: We reviewed the scope of countries, diseases, technologies, and methods involved in the health economic evaluations published in the Middle East and North Africa (MENA) region. ...
Laila Carolina Abu Esba,Hana Abdullah Al-Abdulkarim,Ahmed Alrushidan et al.
Laila Carolina Abu Esba et al.
As the Pharmacy and Therapeutics (P&T) committee acts as an advisory committee on therapeutic options, it is important during pandemics, such as the current Coronavirus disease 2019 pandemic, to quickly search the evidence, be able to selec...